EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overcoming Barriers in Solid Tumors: Lactate-Fueled Nanomotors Enhance Penetration and Reverse Immunosuppression

Juan José Esteve-Moreno, Andrea Escudero, Francisco J Hicke, Víctor Sanz-Álvarez, María Miralles-Buleo, María Dolores Marcos iD, M Carmen Martínez-Bisbal iD, Alba García-Fernández, Paula Díez, Ramón Martínez-Máñez iD

Journal of the American Chemical Society · 2026

DOI: 10.1021/jacs.6c05546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Juan José Esteve-Moreno und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Univer…. Hauptthemen laut MEDLINE: Doxorubicin, Lactic Acid, Nanoparticles. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Generalitat Valenciana, Universitat Polit?cnica de Val?ncia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid tumors present a therapeutic challenge due to their dense extracellular matrix and metabolically immunosuppressive microenvironment, which limit drug penetration and immune clearance. To overcome these barriers, we describe an engineered lactate-powered Janus nanomotor (NM(dox)-LOx) composed of a platinum (Pt) nanodendrite and a mesoporous silica nanoparticle (MSN), loaded with doxorubicin (Dox) and functionalized with the enzyme lactate oxidase (LOx). In this design, LOx acts as a protease-sensitive molecular gate for controlled Dox release and catalyzes the oxidation of tumor-accumulated lactate, using this metabolite as a biofuel to generate hydrogen peroxide, which is catalyzed by Pt into oxygen and water. This cascade generates a self-propulsive force that drives the nanomotor. Concurrently, catalytic lactate depletion reprograms the tumor microenvironment, promoting cytotoxic T cell infiltration and restoring immune activity. NM(dox)-LOx demonstrates efficient tumor accumulation and potent antitumor activity in human SK-MEL-103 and murine B16–F10 melanoma models, including 2D cultures, 3D spheroids, and in vivo tumors. Remarkably, treatment in an in vivo B16–F10 melanoma model achieved pronounced tumor regression and enhanced cytotoxic T cell infiltration, while maintaining minimal systemic toxicity. Overall, this multifunctional nanomotor couples enhanced drug delivery with immune activation, effectively overcoming the structural and metabolic barriers of solid tumors, and represents a promising strategy for self-propelled therapeutic nanoparticles in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinLactic AcidNanoparticlesAnimalsHumansMiceSilicon DioxidePlatinumTumor MicroenvironmentCell Line, TumorDrug CarriersMixed Function Oxygenases

Substanzen

DoxorubicinLactic Acidlactate 2-monooxygenaseSilicon DioxidePlatinumDrug CarriersMixed Function Oxygenases

Autor:innen und Institutionen

  • Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camí de Vera, s/n46022València, Spain.
  • Unidad Mixta UPV-CIPF de Investigación en Mecanismos de Enfermedades y Nanomedicina, Centro de Investigación Príncipe Felipe, Universitat Politècnica de València, C/Eduardo Primo Yúfera, 3, 46012València, Spain.
  • CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029Madrid, Spain.
  • Unidad Mixta de Investigación en Nanomedicina y Sensores, Universitat Politècnica de València, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Avenida Fernando Abril Martorell 106, Torre A, 46026València, Spain.
  • Departamento de Química, Universitat Politècnica de València, Camí de Vera s/n46022València, Spain.
  • Departamento de Química-Física, Universitat de València, Burjassot, 46100, València, Spain.

ORCID-Profile: María Dolores Marcos, M Carmen Martínez-Bisbal, Ramón Martínez-Máñez

Förderung

  • European Research Council
  • Generalitat Valenciana
  • Universitat Polit?cnica de Val?ncia
  • Instituto de Salud Carlos III
  • Ministerio de Universidades
  • Ministerio de Ciencia e Innovaci?n
  • AECC Scientific Foundation

Zitieren

APA

Esteve-Moreno, J. J., Escudero, A., Hicke, F. J., Sanz-Álvarez, V., Miralles-Buleo, M., Marcos, M. D., Martínez-Bisbal, M. C., García-Fernández, A., Díez, P., & Martínez-Máñez, R. (2026). Overcoming Barriers in Solid Tumors: Lactate-Fueled Nanomotors Enhance Penetration and Reverse Immunosuppression. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c05546

Vancouver

Esteve-Moreno JJ, Escudero A, Hicke FJ, Sanz-Álvarez V, Miralles-Buleo M, Marcos MD, et al. Overcoming Barriers in Solid Tumors: Lactate-Fueled Nanomotors Enhance Penetration and Reverse Immunosuppression. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c05546

BibTeX
@article{EsteveMoreno2026,
  author = {Esteve-Moreno, Juan José and Escudero, Andrea and Hicke, Francisco J and Sanz-Álvarez, Víctor and Miralles-Buleo, María and Marcos, María Dolores and Martínez-Bisbal, M Carmen and García-Fernández, Alba and Díez, Paula and Martínez-Máñez, Ramón},
  title = {Overcoming Barriers in Solid Tumors: Lactate-Fueled Nanomotors Enhance Penetration and Reverse Immunosuppression},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.6c05546}
}
Kostenlos starten →